include forward-looking statements

Texas Roadhouse, Inc. (TXRH) Q3 2025 Earnings Call Transcript

**Texas Roadhouse Third Quarter Earnings Conference Call Transcript**

*Good evening, and welcome to the Texas Roadhouse Third Quarter Earnings Conference Call. Today’s call is being recorded.*

—

**Operator Instructions:**
[Operator instructions omitted for brevity.]

—

I would now like to introduce Michael Bailen, Head of Investor Relations for Texas Roadhouse. Michael, you may begin your conference.

—

**David Palmer, Evercore ISI Institutional Equities, Research Division:**
Thank you, Julianne, and good evening, everyone.

By now, you should have access to our earnings release for the third quarter ended September 30, 2025. The release can also be found on our website at [texasroadhouse.com](https://www.texasroadhouse.com) in the Investors section.

I would like to remind everyone that part of our discussion today will include forward-looking statements. These statements are not guarantees of future performance, and, therefore, undue reliance should not be placed upon them.

We refer all of you to our official filings and disclosures for further information.

—
https://seekingalpha.com/article/4839831-texas-roadhouse-inc-txrh-q3-2025-earnings-call-transcript?source=feed_all_articles

Corsair Gaming, Inc. (CRSR) Q3 2025 Earnings Call Transcript

Operator: Ladies and gentlemen, good afternoon, and welcome to Corsair Gaming’s Third Quarter 2025 Earnings Conference Call. As a reminder, today’s call is being recorded, and your participation implies consent to such recording.

[Operator Instructions]

With that, I would now like to turn the call over to David Pasquale with Corsair Investor Relations. Thank you. Sir, please begin.

—

**David Pasquale:**
Thank you, operator. Good afternoon, everyone, and thank you for joining us for Corsair’s Financial Results Conference Call for the third quarter ended September 30, 2025.

On the call today, we have Corsair’s CEO, Thi La, and CFO, Michael Potter. Thi will review highlights from the quarter. Michael will then review the financials and our outlook. Afterward, we will have time for any questions.

Before we begin, allow me to provide a disclaimer regarding forward-looking statements. This call, including the Q&A portion, may include forward-looking statements related to the expected future results for our company and are, therefore, forward-looking statements.

Our actual results may differ materially from our projections due to a number of risks and uncertainties. The risks and uncertainties that forward-looking statements are subject to are described in our earnings release and other SEC filings.

Please note that until our 10-Q has been filed, these numbers are preliminary.

Today’s remarks will also include references to non-GAAP financial measures. Additional information, including reconciliation between non-GAAP financial information and GAAP financial information, is provided in the press release we issued.

—

We look forward to sharing more details on the quarter and engaging with your questions shortly.
https://seekingalpha.com/article/4837926-corsair-gaming-inc-crsr-q3-2025-earnings-call-transcript?source=feed_all_articles

United Therapeutics Corporation (UTHR) Q3 2025 Earnings Call Transcript

Operator: Good morning, everyone, and welcome to the United Therapeutics Corporation Third Quarter 2025 Corporate Update. My name is Jamie, and I will be your conference operator today.

[Operator Instructions]

Please also note today’s event is being recorded. At this time, I’d like to turn the floor over to Harry Silvers, Investor Relations Manager at United Therapeutics.

—

**Harrison Silvers, Manager of Investor Relations:**

Thank you, Jamie. Good morning. It is my pleasure to welcome you to the United Therapeutics Corporation Third Quarter 2025 Corporate Update Webcast.

Remarks today will include forward-looking statements representing our expectations or beliefs regarding future events. These statements involve risks and uncertainties that may cause actual results to differ materially.

Our latest SEC filings, including Forms 10-K and 10-Q, contain additional information on these risks and uncertainties. We assume no obligation to update forward-looking statements.

Today’s remarks may also discuss the progress and results of clinical trials or other developments with respect to our products. These remarks are intended solely to educate investors and are not intended to serve as the basis for medical decision-making or to suggest that any products are safe and effective for any unapproved or investigational uses.

Full prescribing information for the products is available upon request.
https://seekingalpha.com/article/4834678-united-therapeutics-corporation-uthr-q3-2025-earnings-call-transcript?source=feed_all_articles